Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
3,084.00    0.00 (0.00%)
Bid:
3,000.00
Ask:
3,390.00
Spread: 390.00 (13.00%)
Market Cap: £4.30b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

Directorate Change

10 Oct 2014 07:00

RNS Number : 9267T
Croda International PLC
10 October 2014
 



Croda International Plc

 

Appointment of Group Finance Director

 

Croda International Plc ('Croda' or 'the Company') is pleased to announce the appointment of Jez Maiden as Group Finance Director. Jez will join Croda early in the New Year and will succeed Sean Christie who announced in June that he would step down from the role in 2015 after nine years. Sean will leave the Company at the end of April 2015.

 

Jez joins from National Express Group PLC where he has been Group Finance Director since 2008. In addition to his previous position as Group Finance Director at Northern Foods, Jez has been Chief Financial Officer at British Vita plc as well as Group Finance Director at Hickson International plc, both listed speciality chemical companies. He has also served since 2007 as a Non Executive Director of Synthomer plc, a FTSE 250 speciality chemical company, including as Chair of the Audit Committee and Senior Independent Director.

 

Martin Flower, Chairman, said;

 

"I am delighted to welcome Jez to the Croda board. He has an exceptional track record as a Group Finance Director and has had extensive experience working across the speciality chemical sector. He will be a valuable addition to our senior team and we look forward to working with him.

 

On behalf of the board and all my Croda colleagues, I would like to thank Sean Christie for the outstanding contribution he has made to Croda over the last nine years. We wish him all the very best for the future."

There are no further details required to be disclosed under LR 9.6.13R of the Listing Rules of the UK Listing Authority.

 

Enquiries:

 

Croda International PlcSteve Foots, Group Chief ExecutiveSean Christie, Group Finance Director

 

+ 44 (0) 1405 860 551

Pendomer CommunicationsCharles Armitstead

 

+44 (0) 20 3603 5220

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADMMGGDLMGDZM
Date   Source Headline
11th Jun 20262:58 pmRNSDirector/PDMR Shareholding
11th Jun 20269:15 amRNSDirector Declaration
1st Jun 20261:46 pmRNSDirector/PDMR Shareholding
29th May 20264:06 pmRNSDirector/PDMR Shareholding
29th May 20263:10 pmRNSDirector/PDMR Shareholding
29th May 20261:53 pmRNSDirector/PDMR Shareholding
29th May 20261:52 pmRNSDirector/PDMR Shareholding
29th May 20261:45 pmRNSDirector/PDMR Shareholding
15th May 20269:23 amRNSDirector/PDMR Shareholding
12th May 202612:10 pmRNSDirector/PDMR Shareholding
6th May 20261:21 pmRNSDirector/PDMR Shareholding
23rd Apr 202611:20 amRNSResult of AGM
22nd Apr 20267:00 amRNSFirst quarter 2026 sales in line with expectations
13th Apr 20261:41 pmRNSDirector/PDMR Shareholding
31st Mar 202611:48 amRNSHolding(s) in Company
26th Mar 20264:34 pmRNSDirector/PDMR Shareholding
18th Mar 20263:31 pmRNSDirector/PDMR Shareholding
18th Mar 20263:30 pmRNSDirector/PDMR Shareholding
18th Mar 20263:27 pmRNSDirector/PDMR Shareholding
18th Mar 20263:25 pmRNSDirector/PDMR Shareholding
18th Mar 20263:23 pmRNSDirector/PDMR Shareholding
18th Mar 20263:23 pmRNSDirector/PDMR Shareholding
18th Mar 20263:20 pmRNSDirector/PDMR Shareholding
16th Mar 20261:36 pmRNSAnnual Financial Report
16th Mar 20261:36 pmRNSAnnual Financial Report
11th Mar 202611:28 amRNSDirector/PDMR Shareholding
11th Mar 202611:28 amRNSDirector/PDMR Shareholding
6th Mar 20261:32 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:13 pmRNSHolding(s) in Company
24th Feb 20267:00 amRNSResults for the year ended 31 December 2025
11th Feb 20262:59 pmRNSDirector/PDMR Shareholding
13th Jan 20262:47 pmRNSDirector/PDMR Shareholding
9th Jan 20267:00 amRNSDirector Declaration
11th Dec 202511:30 amRNSDirector/PDMR Shareholding
11th Nov 202511:19 amRNSDirector/PDMR Shareholding
16th Oct 20257:00 amRNSThird quarter 2025 sales update
14th Oct 20251:58 pmRNSDirector/PDMR Shareholding
8th Oct 20254:26 pmRNSDirector/PDMR Shareholding
1st Oct 20253:45 pmRNSDirector/PDMR Shareholding
18th Sep 20253:49 pmRNSHolding(s) in Company
12th Sep 202510:11 amRNSDirector/PDMR Shareholding
11th Sep 20253:54 pmRNSDirector/PDMR Shareholding
29th Aug 20253:58 pmRNSHolding(s) in Company
29th Aug 202511:03 amRNSHolding(s) in Company
27th Aug 20251:58 pmRNSHolding(s) in Company
22nd Aug 20254:24 pmRNSDirector/PDMR Shareholding
22nd Aug 202511:55 amRNSDirector/PDMR Shareholding
14th Aug 20259:10 amRNSDirector/PDMR Shareholding
12th Aug 202511:42 amRNSDirector/PDMR Shareholding
7th Aug 20259:16 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.